Proteome Sciences (LON:PRM) Trading Down 11% – Here’s What Happened

Proteome Sciences plc (LON:PRM) shares were down 11% on Wednesday . The stock traded as low as GBX 1.42 and last traded at GBX 1.42. Approximately 32,210 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 417,027 shares. The stock had previously closed at GBX 1.60.

Proteome Sciences Price Performance

The stock’s 50-day moving average is GBX 1.55 and its 200 day moving average is GBX 1.93. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The company has a market cap of £5.86 million, a PE ratio of -1.61 and a beta of 0.07.

Proteome Sciences (LON:PRM) last posted its earnings results on Wednesday, April 15th. The company reported GBX (1.04) EPS for the quarter. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%. The firm had revenue of GBX 376 million for the quarter.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.